Total Liabilities Summary of Shanghai Model Organisms Center, Inc.

Shanghai Model Organisms Center, Inc.'s latest annual total liabilities in 2023 was 260.98 Million CNY , down -9.3% from previous year.
Shanghai Model Organisms Center, Inc.'s latest quarterly total liabilities in 2024 Q3 was 222.4 Million CNY , down -9.12% from previous quarter.
Shanghai Model Organisms Center, Inc. reported annual total liabilities of 287.75 Million CNY in 2022, up 59.51% from previous year.
Shanghai Model Organisms Center, Inc. reported annual total liabilities of 180.39 Million CNY in 2021, up 76.71% from previous year.
Shanghai Model Organisms Center, Inc. reported quarterly total liabilities of 244.05 Million CNY for 2024 Q1, down -6.49% from previous quarter.
Shanghai Model Organisms Center, Inc. reported quarterly total liabilities of 244.73 Million CNY for 2024 Q2, up 0.28% from previous quarter.

Annual Total Liabilities Chart of Shanghai Model Organisms Center, Inc. (2023 - 2015)

Historical Annual Total Liabilities of Shanghai Model Organisms Center, Inc. (2023 - 2015)

Year	Total Liabilities	Total Liabilities Growth
2023	260.98 Million CNY	-9.3%
2022	287.75 Million CNY	59.51%
2021	180.39 Million CNY	76.71%
2020	102.08 Million CNY	22.53%
2019	83.31 Million CNY	4.73%
2018	79.55 Million CNY	-2.48%
2017	81.57 Million CNY	55.77%
2016	52.36 Million CNY	6.91%
2015	48.98 Million CNY	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q3	222.4 Million CNY	-9.12%
2024 Q1	244.05 Million CNY	-6.49%
2024 Q2	244.73 Million CNY	0.28%
2023 Q3	250.7 Million CNY	0.08%
2023 FY	260.98 Million CNY	-9.3%
2023 Q4	260.98 Million CNY	4.1%
2023 Q2	250.5 Million CNY	-15.62%
2023 Q1	296.88 Million CNY	3.17%
2022 FY	287.75 Million CNY	59.51%
2022 Q4	287.75 Million CNY	-21.86%
2022 Q3	368.22 Million CNY	57.91%
2022 Q2	233.18 Million CNY	51.98%
2022 Q1	153.43 Million CNY	-14.95%
2021 Q4	180.39 Million CNY	30.62%
2021 Q2	133.87 Million CNY	-64.5%
2021 FY	180.39 Million CNY	76.71%
2021 Q1	377.15 Million CNY	269.44%
2021 Q3	138.1 Million CNY	3.16%
2020 Q4	102.08 Million CNY	0.0%
2020 Q2	73.82 Million CNY	16.42%
2020 Q1	63.41 Million CNY	0.0%
2020 FY	102.08 Million CNY	22.53%
2020 Q3	- CNY	-100.0%
2019 FY	83.31 Million CNY	4.73%
2018 FY	79.55 Million CNY	-2.48%
2018 Q1	52.6 Million CNY	-15.49%
2018 Q2	52.6 Million CNY	0.0%
2017 Q3	62.24 Million CNY	50.14%
2017 Q2	41.45 Million CNY	0.0%
2017 Q1	41.45 Million CNY	-20.83%
2017 FY	81.57 Million CNY	55.77%
2017 Q4	62.24 Million CNY	0.0%
2016 Q4	52.36 Million CNY	0.0%
2016 FY	52.36 Million CNY	6.91%
2016 Q1	- CNY	0.0%
2016 Q3	52.36 Million CNY	0.0%
2015 FY	48.98 Million CNY	0.0%

Peer Total Liabilities Comparison of Shanghai Model Organisms Center, Inc.

Name	Total Liabilities	Total Liabilities Difference
Beijing Tiantan Biological Products Co., Ltd.	1.33 Billion CNY	80.438%
JiangSu WuZhong Pharmaceutical Development Co., Ltd.	2.56 Billion CNY	89.809%
Jinyu Bio-technology Co., Ltd.	1.21 Billion CNY	78.566%
Vcanbio Cell & Gene Engineering Corp., Ltd	1.61 Billion CNY	83.817%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong	6.65 Billion CNY	96.076%
Zhejiang Ausun Pharmaceutical Co., Ltd.	809.99 Million CNY	67.779%
DaShenLin Pharmaceutical Group Co., Ltd.	16.17 Billion CNY	98.386%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.	2.79 Billion CNY	90.671%
GuiZhou SanLi Pharmaceutical Co.,Ltd	1.17 Billion CNY	77.791%
Pulike Biological Engineering, Inc.	538.33 Million CNY	51.52%
Beijing Konruns Pharmaceutical Co.,Ltd.	418.43 Million CNY	37.629%
Shanghai Hile Bio-Technology Co., Ltd.	482.95 Million CNY	45.961%
Qingdao Vland Biotech INC.	1.15 Billion CNY	77.37%
Zhejiang Shouxiangu Pharmaceutical Co., Ltd.	1 Billion CNY	73.981%
Aurisco Pharmaceutical Co.,Ltd.	607.02 Million CNY	57.006%
Zhejiang East Asia Pharmaceutical Co., Ltd.	1.32 Billion CNY	80.349%
Hainan Huluwa Pharmaceutical Group Co., Ltd.	1.9 Billion CNY	86.272%
Mabwell (Shanghai) Bioscience Co., Ltd.	1.88 Billion CNY	86.131%
Beijing Hotgen Biotech Co., Ltd.	202.56 Million CNY	-28.842%
Assure Tech (Hangzhou) Co., Ltd.	683.82 Million CNY	61.835%
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.	1.28 Billion CNY	79.724%
Cabio Biotech (Wuhan) Co., Ltd.	117.6 Million CNY	-121.923%
Shanghai Shen Lian Biomedical Corporation	86.92 Million CNY	-200.237%
Nanjing Vazyme Biotech Co., Ltd.	1.69 Billion CNY	84.607%
Shandong Kexing Bioproducts Co,.Ltd	1.4 Billion CNY	81.362%
Shanghai Junshi Biosciences Co., Ltd.	3.83 Billion CNY	93.201%
Suzhou Zelgen Biopharmaceuticals Co., Ltd.	1.23 Billion CNY	78.796%
Xiamen Amoytop Biotech Co., Ltd.	479.68 Million CNY	45.592%
Novogene Co., Ltd.	1.12 Billion CNY	76.71%
Shanghai ZJ Bio-Tech Co., Ltd.	241.66 Million CNY	-7.996%
Chengdu Olymvax Biopharmaceuticals Inc.	681.84 Million CNY	61.723%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd	308.14 Million CNY	15.304%
Shanghai Haohai Biological Technology Co., Ltd.	1.07 Billion CNY	75.713%
Jiangsu Bioperfectus Technologies Co., Ltd.	501.3 Million CNY	47.939%
Jiangsu Aidea Pharmaceutical Co., Ltd.	621.02 Million CNY	57.975%
Chengdu Easton Biopharmaceuticals Co., Ltd.	743.33 Million CNY	64.89%
Sinocelltech Group Limited	3.21 Billion CNY	91.892%
Wuhan Keqian Biology Co.,Ltd	833.59 Million CNY	68.692%
Shanghai Allist Pharmaceuticals Co., Ltd.	394.21 Million CNY	33.797%
Anhui Huaheng Biotechnology Co., Ltd.	2.14 Billion CNY	87.83%
Youcare Pharmaceutical Group Co., Ltd.	2.31 Billion CNY	88.72%
Jiangsu gdk Biotechnology Co., Ltd.	260.51 Million CNY	-0.179%
Beijing Kawin Technology Share-Holding Co., Ltd.	663.01 Million CNY	60.637%
Hangzhou Biotest Biotech Co.,Ltd.	158.82 Million CNY	-64.327%

Global Stocks Search

Shanghai Model Organisms Center, Inc. (688265.SS)

Total Liabilities Summary of Shanghai Model Organisms Center, Inc.

Annual Total Liabilities Chart of Shanghai Model Organisms Center, Inc. (2023 - 2015)

Historical Annual Total Liabilities of Shanghai Model Organisms Center, Inc. (2023 - 2015)

Peer Total Liabilities Comparison of Shanghai Model Organisms Center, Inc.